Latest filing published 08 Mar 2022 for CYTOKINETICS INC, €183k.
Filing timeline
BuySaleInsider track record
David Cragg: trading record in brief
David Cragg is a declared insider of Cytokinetics Inc (senior executive), with filings sourced from SEC (Form 4). Between 4 September 2012 and 7 March 2022, the trades on record add up to 46 filings.
On the market, this insider has only sold: 10 sales, €3.3M in total. Besides market trades, the filings include 26 share grants and 10 option exercises.
The latest filing, published on 8 March 2022, reports a share grant of €183k in Cytokinetics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David Cragg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,399 shares@ US$36.8314.6% of flowCommon StockSEC:0001061983-22-000067:0
- 20,000 shares0Common StockSEC:0001061983-22-000053:1
- 3,458 shares@ US$37.639.3% of flowCommon StockSEC:0001061983-22-000053:0
- 2,071 shares@ US$35.325.2% of flowCommon StockSEC:0001061983-22-000037:0
- 3,125 shares0Common StockSEC:0001061983-22-000025:1
- 1,883 shares0Common StockSEC:0001061983-22-000025:0
- 24,519 shares@ US$41.7617.9% of flowCommon StockSEC:0001061983-21-000255:1
- 20,481 shares@ US$9.653.5% of flowCommon StockSEC:0001061983-21-000255:2
- 20,481 shares@ US$41.7615.0% of flowCommon StockSEC:0001061983-21-000255:3
- 24,519 shares@ US$9.6516.3% of flowCommon StockSEC:0001061983-21-000255:0
- 6,675 shares@ US$34.894.1% of flowCommon StockSEC:0001061983-21-000247:1
- 18,325 shares@ US$6.001.9% of flowCommon StockSEC:0001061983-21-000247:2
- 18,325 shares@ US$34.8911.2% of flowCommon StockSEC:0001061983-21-000247:3
- 6,675 shares@ US$6.002.8% of flowCommon StockSEC:0001061983-21-000247:0
- 7,569 shares@ US$35.14218.4% of flowCommon StockSEC:0001061983-21-000219:0
- 7,850 shares@ US$32.778517.4% of flowCommon StockSEC:0001061983-21-000208:0
- 2,616 shares@ US$29.675.2% of flowCommon StockSEC:0001061983-21-000200:0
- 6,013 shares@ US$19.87018.1% of flowCommon StockSEC:0001061983-21-000162:0
- 6,562 shares@ US$21.632.4% of flowCommon StockSEC:0001061983-21-000154:1
- 8,437 shares@ US$6.300.9% of flowCommon StockSEC:0001061983-21-000154:2
- 8,437 shares@ US$21.633.0% of flowCommon StockSEC:0001061983-21-000154:3
- 6,562 shares@ US$6.302.7% of flowCommon StockSEC:0001061983-21-000154:0
- 4,150 shares@ US$19.191.4% of flowCommon StockSEC:0001061983-21-000075:0
- 25,000 shares0Common StockSEC:0001061983-21-000058:0
- 2,075 shares@ US$19.660.7% of flowCommon StockSEC:0001061983-21-000048:0
25 of 46 declarations
